Company: HCWB
Filing Date: 2025-06-23
Form Type: 8-K
Source: 0000950170-25-089035
Chunk: 2

Company: HCW Biologics Inc.
Filing Date: 2025-06-23
Form: 8-K
Item: Item 8.01
Chunk 2
---
Item 8.01 Other Events.

During the Annual Meeting, the Company’s service provider, Broadridge Financial Solutions, Inc., experienced technical difficulties that may have prevented stockholders from joining the virtual meeting; however, a quorum at the Annual Meeting was reached through the attendance in person or by proxy of persons, who, as of the record date of April 22, 2025, held a majority of the voting power of the shares of our common stock entitled to vote at the Annual Meeting. Accordingly, The Annual Meeting was validly held.

Broadridge will send a letter to the Company’s stockholders that includes links to the replay of the Annual Meeting and a platform where stockholders can submit questions. A copy of this letter is furnished as Exhibit 99.1 to this Form 8-K. The Company has also posted the letter on its investor website at: https://investors. hcwbiologics. com/.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                   
         99.1      Letter to HCW Biologics Inc. Stockholders dated June 23, 2025.                
 ─────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document).